HRSA Issues Wide-Ranging 340B Guidance

By Michelle M. Stein / August 27, 2015 at 7:22 PM
The Health Resources and Services Administration proposed Thursday (Aug. 27) long-awaited guidance on the 340B drug discount program, clarifying the definition of a 340B patient, contract pharmacy arrangements, audit procedures and avoiding duplicate discounts, among other provisions. “The goal of issuing this guidance is to continue to strengthen program integrity and oversight while assisting covered entities and manufacturers to ensure that safety-net providers remain able to carry out the intent of the 340B Program -- to stretch scarce Federal resources...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.